{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:45:54Z","timestamp":1759513554255},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue de Stomatologie et de Chirurgie Maxillo-faciale"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.stomax.2009.07.002","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T04:20:42Z","timestamp":1255666842000},"page":"306-308","source":"Crossref","is-referenced-by-count":10,"title":["Carcinome jugal sous \u00e9tanercept"],"prefix":"10.1016","volume":"110","author":[{"given":"A.","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Taberne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Siberchicot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Fricain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Zwetyenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.stomax.2009.07.002_bib1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMcibr0803116","article-title":"Tumor necrosis factor alpha and colitis-associated colon cancer","volume":"358","author":"Wilson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.stomax.2009.07.002_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00002018-200831050-00013","article-title":"TNF-alpha inhibitors and leukaemia: international pharmacovigilance reports","volume":"31","author":"Meyboom","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.stomax.2009.07.002_bib3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ajh.20926","article-title":"TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature","volume":"82","author":"Nair","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.stomax.2009.07.002_bib4","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2006.12.024","article-title":"Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies","volume":"56","author":"Fulchiero","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.stomax.2009.07.002_bib5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s10067-006-0454-4","article-title":"Atypical carcinoid tumor of the thymus with ectopic ACTH production developed during the course of etanercept treatment--case report","volume":"26","author":"Simsek","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.stomax.2009.07.002_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","article-title":"Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial","volume":"54","author":"Stone","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.stomax.2009.07.002_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaad.2004.07.031","article-title":"Rapid onset of cutaneous squamous cell carcinoma of the penis in a patient with psoriasis on etanercept therapy","volume":"51","author":"Fryrear","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.stomax.2009.07.002_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.stomax.2009.07.002_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/S0190-9622(03)00811-9","article-title":"Etanercept and squamous cell carcinoma","volume":"49","author":"Burge","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.stomax.2009.07.002_bib10","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: 26\u00a0cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Revue de Stomatologie et de Chirurgie Maxillo-faciale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035176809001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035176809001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T20:22:03Z","timestamp":1544905323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035176809001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0035176809001399"],"URL":"https:\/\/doi.org\/10.1016\/j.stomax.2009.07.002","relation":{},"ISSN":["0035-1768"],"issn-type":[{"value":"0035-1768","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}